{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:31:31Z","timestamp":1778517091658,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune rheumatic disease that is associated with multiple comorbidities and has a significant economic impact on the Spanish health system. The objective of this study was to estimate the rates of hospitalization of rheumatoid arthritis in Spain, and describing hospitalization rates and their changing by age, region, RA variant, and when RA as a main cause of hospitalization or a comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Observational descriptive study that reviewed hospital records from the CMBD. We included all hospitalizations of patients in Spain whose main diagnosis or comorbidity in the ICD-9-CM was rheumatoid arthritis during the period of 2002\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 315,190 hospitalizations with the RA code were recorded; 67.3% were in women. The mean age of the patients was 68.5\u2009\u00b1\u200913.9\u2009years. The median length of hospital stay was 7\u2009days (IQR 3\u201311\u2009days). In 29,809 of the admissions, RA was coded as the main diagnosis (9.4%). When RA was not coded as the main diagnosis, the most frequent main diagnoses were diseases of the circulatory system (18.9%) and diseases of the respiratory system (17.4%). The hospitalization rate during the period of 2002\u20132017 was 43.8 (95% CI: 43.7\u201344.0) per 100,000 inhabitants\u00a0and constantly increased during the period. The total cost for the healthcare system was 1.476 million euros, with a median of 3542 euros per hospitalization (IQR 2646\u20135222 euros).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Spain, the hospitalization rate of patients with RA increased during the study period, despite the decrease in the hospitalization rate when RA was the main diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05243-0","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T07:02:57Z","timestamp":1588575777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hospitalization burden and comorbidities of patients with rheumatoid arthritis in Spain during the period 2002\u20132017"],"prefix":"10.1186","volume":"20","author":[{"given":"Mario","family":"Gil-Conesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Del-Moral-Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Gil-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Gil-de-Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Mazzuccheli-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-6003","authenticated-orcid":false,"given":"Gil","family":"Rodr\u00edguez-Caravaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"5243_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.reuma.2009.10.006","volume":"6","author":"J Tornero","year":"2010","unstructured":"Tornero J, Sanmart\u00ed R, Rodr\u00edguez V, Mart\u00edn E, Marenco JL, Gonz\u00e1lez I, et al. Update of the consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis. Reumatol Clin. 2010;6:23\u201336.","journal-title":"Reumatol Clin"},{"key":"5243_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semarthrit.2013.08.004","volume":"43","author":"M Cutolo","year":"2014","unstructured":"Cutolo M, Kitas GD, Van Riel PL. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin Arthritis Rheum. 2014;43:479\u201388.","journal-title":"Semin Arthritis Rheum"},{"key":"5243_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/acr.23539","volume":"70","author":"RA Marrie","year":"2018","unstructured":"Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased burden of psychiatric disorders in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2018;70:970\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5243_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/1471-2458-12-397","volume":"12","author":"B Nordgren","year":"2012","unstructured":"Nordgren B, Frid\u00e9n C, Demmelmaier I, Bergstr\u00f6m G, Opava CH. Long-term health-enhancing physical activity in rheumatoid arthritis-the PARA 2010 study. BMC Public Health. 2012;12:397.","journal-title":"BMC Public Health"},{"key":"5243_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/acr.22642","volume":"68","author":"BR England","year":"2016","unstructured":"England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, et al. Cause-specific mortality in male US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68:36\u201345.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5243_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.semarthrit.2007.08.006","volume":"37","author":"L Ab\u00e1solo","year":"2008","unstructured":"Ab\u00e1solo L, J\u00fadez E, Descalzo MA, Gonz\u00e1lez I, Jover JA, Carmona L, et al. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south European population. Semin Arthritis Rheum. 2008;37:388\u201397.","journal-title":"Semin Arthritis Rheum"},{"key":"5243_CR7","unstructured":"World Health Organization. Global Action Plan for the prevention and control of noncommunicable diseases 2013-2020. [cited 2019 Feb 10]. Available from: http:\/\/www.who.int\/nmh\/events\/ncd_action_plan\/en\/."},{"key":"5243_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/1471-2458-12-496","volume":"12","author":"M Van Vilsteren","year":"2012","unstructured":"Van Vilsteren M, Boot CR, Steenbeek R, Van Schaardenburg D, Voskuy AE, Anema JR. An intervention program with the aim to improve and maintain work productivity for workers with rheumatoid arthritis: design of a randomized controlled trial and cost-effectiveness study. BMC Public Health. 2012;12:496.","journal-title":"BMC Public Health"},{"key":"5243_CR9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1316\u201322.","journal-title":"Ann Rheum Dis"},{"key":"5243_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/rheumatology\/41.1.88","volume":"41","author":"L Carmona","year":"2002","unstructured":"Carmona L, Villaverde V, Hern\u00e1ndez-Garc\u00eda C, Ballina J, Gabriel R, Laffon A, et al. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford). 2002;41:88\u201395.","journal-title":"Rheumatology (Oxford)"},{"key":"5243_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/rheumatology\/ken205","volume":"47","author":"J Carbonell","year":"2008","unstructured":"Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L, SERAP Study Group. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology (Oxford). 2008;47:1088\u201392.","journal-title":"Rheumatology (Oxford)"},{"key":"5243_CR12","first-page":"48","volume-title":"Encuesta Nacional De Salud: ENSE 2011-2012","author":"Ministerio de Sanidad Servicios Sociales e Igualdad","year":"2013","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad. Encuesta Nacional De Salud: ENSE 2011-2012; 2013. p. 48."},{"key":"5243_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1699-258X(05)72744-3","volume":"1","author":"MD Ruiz","year":"2005","unstructured":"Ruiz MD, Hern\u00e1ndez B, Ariza R, Carmona L, Ballina J, Navarro F. An\u00e1lisis de costes en una cohorte de enfermos con artritis reumatoide atendidos en \u00e1rea especializada de reumatolog\u00eda en Espa\u00f1a. Reumatol Clin. 2005;1:193\u20139.","journal-title":"Reumatol Clin"},{"key":"5243_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.rce.2010.02.002","volume":"210","author":"A Jim\u00e9nez","year":"2010","unstructured":"Jim\u00e9nez A, Garc\u00eda J, Lara A. Information systems for clinicians I. how to know what type of patients are attended in our hospitals. Rev Clin Esp. 2010;210:298\u2013303.","journal-title":"Rev Clin Esp"},{"issue":"3","key":"5243_CR15","doi-asserted-by":"publisher","first-page":"e0151563","DOI":"10.1371\/journal.pone.0151563","volume":"11","author":"R Gil-Prieto","year":"2016","unstructured":"Gil-Prieto R, Pascual-Garcia R, San-Roman-Montero J, Martinez-Martin P, Castrodeza-Sanz J, Gil-de-Miguel A. Measuring the burden of hospitalization in patients with Parkinson\u2019s disease in Spain. PLos One. 2016;11(3):e0151563.","journal-title":"PLos One"},{"key":"5243_CR16","unstructured":"An\u00e1lisis y desarrollo de los GDR en el Sistema Nacional de Salud. [cited 2019 Apr 12]. Available from: http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/docs\/analisis.pdf."},{"key":"5243_CR17","unstructured":"Instituto Nacional de Estad\u00edstica. [cited 2019 May 1]. Available from: http:\/\/www.ine.es\/jaxi\/Tabla.htm?path=\/t20\/e245\/p08\/l0\/&file=02002.px."},{"key":"5243_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/ard.60.11.1040","volume":"60","author":"L Carmona","year":"2001","unstructured":"Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60:1040\u20135.","journal-title":"Ann Rheum Dis"},{"key":"5243_CR19","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1136\/annrheumdis-2016-210146","volume":"76","author":"M Moradi-Lakeh","year":"2017","unstructured":"Moradi-Lakeh M, Forouzanfar MH, Emil Vollset S, El Bcheraoui C, Daoud F, Afshin A, Raghid C, Khalil I, Higashi H, Magdy M, El Razek A, Ahmad Kiadaliri A, Khurshid A, Akseer N, et al. Burden of musculoskeletal disorders in the eastern Mediterranean region, 1990\u20132013: findings from the global burden of disease study 2013. Ann Rheum Dis. 2017;76:1365\u201373.","journal-title":"Ann Rheum Dis"},{"key":"5243_CR20","first-page":"126","volume":"3","author":"P Andrade","year":"2017","unstructured":"Andrade P, Sacrist\u00e1n JA, Rentero ML, Hammen V, Dilla T. The burden of rheumatoid arthritis in Spain. Health Econ Outcome Res Open Access. 2017;3:126.","journal-title":"Health Econ Outcome Res Open Access"},{"key":"5243_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625\u201339.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5243_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.rce.2017.01.007","volume":"217","author":"P Rom\u00e1n","year":"2017","unstructured":"Rom\u00e1n P, Ruiz-Cantero A. Polypathology, an emerging phenomenon and a challenge for healthcare systems. Rev Clin Esp. 2017;217:229\u201337.","journal-title":"Rev Clin Esp"},{"key":"5243_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40273-014-0174-6","volume":"32","author":"T Uhlig","year":"2014","unstructured":"Uhlig T, Moe RH, Kvien TK. The Burden of Disease in Rheumatoid Arthritis. Pharmacoeconomics. 2014;32:841\u201351. https:\/\/doi.org\/10.1007\/s40273-014-0174-6.","journal-title":"Pharmacoeconomics"},{"key":"5243_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.berh.2010.10.001","volume":"24","author":"L Carmona","year":"2010","unstructured":"Carmona L, Cross M, Williams B, Lassere M, March L. Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010;24:733\u201345.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5243_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatol. 2013;52:53\u201361.","journal-title":"Rheumatol"},{"key":"5243_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/annrheumdis-2014-eular.2815","volume":"73","author":"V Villaverde","year":"2014","unstructured":"Villaverde V, Loza E, Ortiz A, Martinez-Lopez JA, Toledano E, Lajas C, et al. A systematic literature review of the impact of comorbidity on quality of life and costs in patients with rheumatoid arthritis. The Gecoar Study. Ann Rheum Dis. 2014;73:418.","journal-title":"Ann Rheum Dis"},{"key":"5243_CR27","first-page":"117","volume":"34","author":"CH Roux","year":"2007","unstructured":"Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, et al. Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France. J Rheumatol. 2007;34:117\u201322.","journal-title":"J Rheumatol"},{"key":"5243_CR28","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/archinte.168.15.1664","volume":"168","author":"KH Costenbader","year":"2008","unstructured":"Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med. 2008;168:1664\u201370.","journal-title":"Arch Intern Med"},{"key":"5243_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/CLEP.S129779","volume":"9","author":"V Ehrenstein","year":"2017","unstructured":"Ehrenstein V, Nielsen H, Pedersen AB, Johnsen SP, Pedersen L. Clinical epidemiology in the era of big data: new opportunities, familiar challenges. Clin Epidemiol. 2017;9:245\u201350.","journal-title":"Clin Epidemiol"},{"key":"5243_CR30","unstructured":"Rodr\u00edguez MM, Perea-Milla E, Librero J, Buz\u00f3n ML, Rivas F. An\u00e1lisis del control de calidad del Conjunto M\u00ednimo de Datos B\u00e1sicos de Andaluc\u00eda de los a\u00f1os 2000 a 2003. Grupo VPM-IRYSS."},{"key":"5243_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12916-014-0236-9","volume":"12","author":"JM Haro","year":"2014","unstructured":"Haro JM, Tyrovolas S, Garin N, Diaz-Torne C, Carmona L, Sanchez-Riera L, Perez-Ruiz F, Christopher JL, Murray CJ. The burden of disease in Spain: results from the global burden of disease study 2010. BMC Med. 2014;12:236.","journal-title":"BMC Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05243-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T19:34:35Z","timestamp":1620070475000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05243-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05243-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13530\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13530\/v2","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"12 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval was needed for this study because it was based on secondary analysis of the data obtained from the CMBD (Minimum Basic Data Set) of the Ministry of Health, Social Services and Equality of Spain. The data were completely anonymous and this study uses data with no identifiable information on the survey participants. The Ministry of Health, Social Services and Equality of Spain (Subdirecci\u00f3n General del Instituto de Informaci\u00f3n) gave us administrative permission to access and use the data on which this study is based.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}